交易 ADMA Biologics, Inc. - ADMA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.0314 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
ADMA Biologics Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 6.5793 | -0.1200 | -1.79% | 6.6993 | 6.7293 | 6.4993 |
Mar 27, 2024 | 6.7293 | 0.1800 | 2.75% | 6.5493 | 6.7293 | 6.4793 |
Mar 26, 2024 | 6.4793 | 0.0100 | 0.15% | 6.4693 | 6.5993 | 6.4693 |
Mar 25, 2024 | 6.3793 | 0.0900 | 1.43% | 6.2893 | 6.4893 | 6.2693 |
Mar 22, 2024 | 6.2793 | 0.0300 | 0.48% | 6.2493 | 6.4493 | 6.2193 |
Mar 21, 2024 | 6.1793 | -0.0900 | -1.44% | 6.2693 | 6.4193 | 6.1393 |
Mar 20, 2024 | 6.3093 | 0.1700 | 2.77% | 6.1393 | 6.3093 | 6.0793 |
Mar 19, 2024 | 6.1693 | 0.2600 | 4.40% | 5.9093 | 6.1693 | 5.8693 |
Mar 18, 2024 | 5.9293 | -0.0800 | -1.33% | 6.0093 | 6.0193 | 5.9093 |
Mar 15, 2024 | 5.9793 | 0.0300 | 0.50% | 5.9493 | 6.0393 | 5.8693 |
Mar 14, 2024 | 6.0093 | -0.1600 | -2.59% | 6.1693 | 6.2293 | 5.9993 |
Mar 13, 2024 | 6.2493 | 0.0600 | 0.97% | 6.1893 | 6.2493 | 6.1193 |
Mar 12, 2024 | 6.2093 | 0.0700 | 1.14% | 6.1393 | 6.3393 | 6.1093 |
Mar 11, 2024 | 6.1693 | -0.1400 | -2.22% | 6.3093 | 6.3093 | 6.0893 |
Mar 8, 2024 | 6.3293 | 0.1100 | 1.77% | 6.2193 | 6.3993 | 6.1993 |
Mar 7, 2024 | 6.1493 | -0.0100 | -0.16% | 6.1593 | 6.3893 | 6.0793 |
Mar 6, 2024 | 6.1093 | 0.2700 | 4.62% | 5.8393 | 6.1693 | 5.6993 |
Mar 5, 2024 | 5.7793 | 0.0900 | 1.58% | 5.6893 | 5.7993 | 5.6693 |
Mar 4, 2024 | 5.6993 | 0.1500 | 2.70% | 5.5493 | 5.7893 | 5.5093 |
Mar 1, 2024 | 5.4993 | 0.1400 | 2.61% | 5.3593 | 5.5493 | 5.3093 |
ADMA Biologics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 8, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 ADMA Biologics Inc Earnings Release Q1 2024 ADMA Biologics Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, June 5, 2024 | ||
時間 (UTC) 14:00 | 國家 US
| 事件 ADMA Biologics Inc Annual Shareholders Meeting ADMA Biologics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 154.08 | 80.9426 | 42.2198 | 29.3491 | 16.9853 |
收入 | 154.08 | 80.9426 | 42.2198 | 29.3491 | 16.9853 |
收入成本,共計 | 118.815 | 79.7693 | 61.2914 | 39.5042 | 42.1946 |
毛利 | 35.2651 | 1.17329 | -19.0716 | -10.1552 | -25.2094 |
總營業費用 | 200.115 | 139.316 | 106.143 | 80.7359 | 77.2742 |
銷售/一般/行政費用,總計 | 70.3011 | 55.1856 | 39.2209 | 28.0804 | 30.3085 |
研究與開發 | 3.61376 | 3.64606 | 5.90701 | 2.34385 | 3.92612 |
異常費用(收入) | 6.66994 | 0 | -0.9918 | 9.9625 | 0 |
營業收入 | -46.035 | -58.3737 | -63.9231 | -51.3868 | -60.2889 |
利息收入(費用),非經營淨值 | -19.2345 | -13.0223 | -11.6969 | -8.19259 | -5.32738 |
其他,淨值 | -0.63439 | -0.25158 | -0.12853 | -0.22732 | -0.12712 |
稅前淨收入 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
稅後淨收入 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
未計算非常項目前的淨收益 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
淨收入 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
普通股股東可獲收益 (不含非經常性項目) | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
普通股股東可獲收益 (含非經常性項目) | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
攤薄淨收入 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
攤薄後加權平均股 | 197.875 | 139.579 | 86.1451 | 54.3481 | 45.1889 |
扣除特別項目的每股攤薄盈利 | -0.33306 | -0.51331 | -0.87931 | -0.88833 | -1.45486 |
每股正常攤薄盈利 | -0.29935 | -0.51331 | -0.89083 | -0.91713 | -1.45486 |
Depreciation / Amortization | 0.71535 | 0.71535 | 0.71535 | 0.84494 | 0.84494 |
非常規項目總計 | |||||
Gain (Loss) on Sale of Assets | 0 | 11.5274 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 60.1232 | 56.9135 | 49.9815 | 41.0901 | 33.905 |
收入 | 60.1232 | 56.9135 | 49.9815 | 41.0901 | 33.905 |
收入成本,共計 | 43.4332 | 40.4005 | 35.8044 | 31.4335 | 26.1356 |
毛利 | 16.69 | 16.513 | 14.1771 | 9.65664 | 7.7694 |
總營業費用 | 60.5963 | 57.7268 | 56.04 | 50.4069 | 43.0798 |
銷售/一般/行政費用,總計 | 15.581 | 16.2921 | 18.9825 | 17.7526 | 15.8919 |
研究與開發 | 1.40326 | 0.85535 | 1.07432 | 1.04195 | 0.87339 |
Depreciation / Amortization | 0.17884 | 0.17884 | 0.17884 | 0.17884 | 0.17884 |
營業收入 | -0.47308 | -0.81332 | -6.05854 | -9.31673 | -9.17474 |
利息收入(費用),非經營淨值 | -5.88481 | -5.94851 | -5.73469 | -5.57313 | -4.57075 |
其他,淨值 | -0.01283 | -0.02698 | -0.43845 | -0.00964 | -0.01942 |
稅前淨收入 | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
稅後淨收入 | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
未計算非常項目前的淨收益 | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
淨收入 | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
普通股股東可獲收益 (不含非經常性項目) | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
普通股股東可獲收益 (含非經常性項目) | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
攤薄淨收入 | -6.37071 | -6.78882 | -12.2317 | -14.8995 | -13.7649 |
攤薄後加權平均股 | 222.683 | 221.922 | 202.885 | 196.384 | 196.353 |
扣除特別項目的每股攤薄盈利 | -0.02861 | -0.03059 | -0.06029 | -0.07587 | -0.0701 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.02861 | -0.03059 | -0.06029 | -0.07587 | -0.0701 |
異常費用(收入) | 0 | 0 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 270.402 | 208.729 | 153.741 | 85.8204 | 44.5296 |
現金和短期投資 | 86.5215 | 51.0891 | 55.9212 | 26.7521 | 22.7549 |
現金等價物 | 86.5215 | 51.0891 | 55.9212 | 26.7521 | 22.7549 |
短期投資 | |||||
應收賬款總額,淨額 | 15.505 | 28.5769 | 13.2373 | 3.46992 | 1.39244 |
應收賬款 - 貿易,淨額 | 15.505 | 28.5769 | 13.2373 | 3.46992 | 1.39244 |
總庫存 | 163.28 | 124.724 | 81.5356 | 53.0647 | 18.6162 |
預付的費用 | 5.09515 | 4.33925 | 3.04647 | 2.53359 | 1.76616 |
總資産 | 348.462 | 276.253 | 207.673 | 127.091 | 88.8765 |
物業/廠房/設備,總計 - 淨額 | 68.7469 | 58.1977 | 45.8523 | 33.1413 | 30.1157 |
物業/廠房/設備,總計 - 總額 | 88.2235 | 71.4696 | 54.7162 | 38.8663 | 33.5368 |
累計折舊,總計 | -19.4765 | -13.2718 | -8.86394 | -5.72496 | -3.42103 |
其他長期資産,總計 | 4.77025 | 4.0674 | 2.10698 | 1.44004 | 6.69725 |
流動負債總額 | 39.2669 | 30.3783 | 19.9474 | 14.0279 | 9.62505 |
應付賬款 | 13.2294 | 12.4294 | 11.0737 | 9.17459 | 5.90039 |
預提費用 | 24.0989 | 16.7941 | 8.73083 | 4.71047 | 3.58182 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | |||||
其他流動負債,總計 | 1.93864 | 1.15482 | 0.14283 | 0.14283 | 0.14283 |
負債總額 | 196.488 | 135.08 | 119.424 | 100.898 | 69.1061 |
長期債務總額 | 142.833 | 94.8662 | 92.9689 | 83.1992 | 44.075 |
長期債務 | 142.833 | 94.8662 | 92.9689 | 83.1992 | 44.075 |
其他負債,總計 | 14.3877 | 9.8356 | 6.50774 | 3.67047 | 15.406 |
股權 | 151.974 | 141.173 | 88.2494 | 26.1931 | 19.7704 |
普通股 | 0.02218 | 0.01958 | 0.01049 | 0.00593 | 0.00464 |
額外實收資本 | 629.969 | 553.266 | 428.704 | 290.904 | 236.203 |
留存收益(累計赤字) | -478.017 | -412.113 | -340.465 | -264.717 | -216.437 |
總負債和股東權益 | 348.462 | 276.253 | 207.673 | 127.091 | 88.8765 |
已發行普通股總數 | 221.817 | 195.814 | 104.903 | 59.3184 | 46.3531 |
其他流動資産,總計 | 0 | ||||
商譽,淨額 | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
無形資産,淨額 | 1.01342 | 1.72877 | 2.44412 | 3.15947 | 4.00441 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 273.699 | 266.243 | 264.086 | 270.402 | 224.095 |
現金和短期投資 | 74.1568 | 62.5129 | 69.2042 | 86.5215 | 34.906 |
現金等價物 | 74.1568 | 62.5129 | 69.2042 | 86.5215 | 34.906 |
應收賬款總額,淨額 | 31.3187 | 36.7316 | 26.5185 | 15.505 | 20.9024 |
應收賬款 - 貿易,淨額 | 31.3187 | 36.7316 | 26.5185 | 15.505 | 20.9024 |
總庫存 | 163.116 | 161.78 | 163.985 | 163.28 | 162.914 |
預付的費用 | 5.10746 | 5.21874 | 4.37868 | 5.09515 | 5.37248 |
總資産 | 348.997 | 343.027 | 340.788 | 348.462 | 300.558 |
物業/廠房/設備,總計 - 淨額 | 64.5683 | 66.3094 | 67.6185 | 68.7469 | 67.282 |
物業/廠房/設備,總計 - 總額 | 89.6843 | 89.5134 | 88.9036 | 88.2235 | 85.1784 |
累計折舊,總計 | -25.116 | -23.2039 | -21.2852 | -19.4765 | -17.8964 |
商譽,淨額 | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
無形資産,淨額 | 0.4769 | 0.65574 | 0.83458 | 1.01342 | 1.19225 |
其他長期資産,總計 | 6.72282 | 6.28905 | 4.71876 | 4.77025 | 4.45932 |
流動負債總額 | 41.8409 | 41.9525 | 36.7278 | 39.2669 | 44.4403 |
應付賬款 | 10.8514 | 12.0845 | 12.9565 | 13.2294 | 25.1978 |
預提費用 | 28.2332 | 27.5276 | 21.5867 | 24.0989 | 16.994 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.75622 | 2.34033 | 2.18469 | 1.93864 | 2.24849 |
負債總額 | 197.559 | 196.265 | 195.133 | 196.488 | 200.173 |
長期債務總額 | 142.026 | 140.312 | 144.301 | 142.833 | 141.366 |
長期債務 | 142.026 | 140.312 | 144.301 | 142.833 | 141.366 |
其他負債,總計 | 13.6928 | 14.0002 | 14.1042 | 14.3877 | 14.367 |
股權 | 151.437 | 146.762 | 145.655 | 151.974 | 100.385 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.0226 | 0.02245 | 0.02223 | 0.02218 | 0.01968 |
額外實收資本 | 640.026 | 637.916 | 630.438 | 629.969 | 566.15 |
留存收益(累計赤字) | -488.611 | -491.176 | -484.805 | -478.017 | -465.785 |
總負債和股東權益 | 348.997 | 343.027 | 340.788 | 348.462 | 300.558 |
已發行普通股總數 | 225.958 | 224.527 | 222.263 | 221.817 | 196.777 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -65.904 | -71.6476 | -75.7486 | -48.2793 | -65.7434 |
經營活動産生的現金 | -59.5083 | -112.369 | -102.003 | -76.1935 | -62.6787 |
經營活動産生的現金 | 7.11337 | 5.4955 | 3.94229 | 3.25815 | 3.4464 |
非現金物品 | 17.5676 | 5.46355 | 3.58462 | 2.33044 | 3.30681 |
已付現金利息 | 13.88 | 11.1595 | 10.2676 | 8.11223 | 4.39997 |
營運資金的變化 | -18.2853 | -51.6804 | -33.7813 | -33.5028 | -3.68844 |
投資活動産生的現金 | -13.9112 | -13.5113 | -12.7247 | -3.81184 | -2.0956 |
資本支出 | -13.9112 | -13.5113 | -12.7267 | -3.81184 | -2.0956 |
其他投資現金流量項目,總計 | 0 | 0.002 | 0 | ||
融資活動産生的現金 | 108.852 | 121.048 | 143.897 | 80.0026 | 42.9216 |
融資現金流項目 | -7.68177 | -0.0616 | -0.83 | -10.9395 | 0 |
股票的發行(報廢),淨額 | 64.8203 | 121.144 | 131.209 | 48.4721 | 42.9578 |
債務的發行(退還),淨額 | 51.7133 | -0.0343 | 13.5179 | 42.47 | -0.03628 |
現金淨變化 | 35.4324 | -4.83203 | 29.169 | -0.00272 | -21.8527 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -6.78882 | -65.904 | -53.6723 | -38.7728 | -25.0079 |
Cash From Operating Activities | -14.7223 | -59.5083 | -52.1289 | -38.8442 | -26.0134 |
Cash From Operating Activities | 2.03297 | 7.11337 | 5.17649 | 3.3145 | 1.59022 |
Non-Cash Items | 2.56042 | 17.5676 | 14.6492 | 11.4063 | 8.86246 |
Cash Interest Paid | 4.63928 | 13.88 | 9.61036 | 5.98933 | 2.52599 |
Changes in Working Capital | -12.5268 | -18.2853 | -18.2824 | -14.7922 | -11.4582 |
Cash From Investing Activities | -1.9446 | -13.9112 | -10.1627 | -6.78217 | -2.84209 |
Capital Expenditures | -1.9446 | -13.9112 | -10.1627 | -6.78217 | -2.84209 |
Other Investing Cash Flow Items, Total | |||||
Cash From Financing Activities | -0.65051 | 108.852 | 46.1085 | 46.9523 | 47.2713 |
Financing Cash Flow Items | -0.64095 | -7.68177 | -5.61423 | -4.77968 | -4.46973 |
Issuance (Retirement) of Stock, Net | 64.8203 | 0 | 0 | 0 | |
Issuance (Retirement) of Debt, Net | -0.00956 | 51.7133 | 51.7227 | 51.732 | 51.7411 |
Net Change in Cash | -17.3174 | 35.4324 | -16.1831 | 1.32594 | 18.4158 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biopharmaceuticals |
C/O Adma Biologics, Inc.
465 State Route 17
RAMSEY
NEW JERSEY 07446
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易